These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7451803)

  • 21. An overview of enhancement techniques for peripheral field loss.
    Cohen JM
    J Am Optom Assoc; 1993 Jan; 64(1):60-70. PubMed ID: 8454830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual field recovery after vision restoration therapy (VRT) is independent of eye movements: an eye tracker study.
    Kasten E; Bunzenthal U; Sabel BA
    Behav Brain Res; 2006 Nov; 175(1):18-26. PubMed ID: 16970999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prescribing low vision aids: a report from a new low vision clinic.
    Struve CA
    Tex Med; 1973 Aug; 69(8):76-80. PubMed ID: 4732464
    [No Abstract]   [Full Text] [Related]  

  • 24. [Visual aids].
    Thibaudeau J
    Union Med Can; 1966 Nov; 95(11):1279-81. PubMed ID: 5979616
    [No Abstract]   [Full Text] [Related]  

  • 25. Correlation of blue-on-yellow visual fields with scanning confocal laser optic disc measurements.
    Teesalu P; Vihanninjoki K; Airaksinen PJ; Tuulonen A; Läärä E
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2452-9. PubMed ID: 9375562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vigabatrin and visual field defects. A Danish material with evaluation of different screening methods].
    Riise P; Fledelius HC; Rogvi-Hansen Bà
    Ugeskr Laeger; 2003 Mar; 165(10):1034-8. PubMed ID: 12645411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving residual vision by attentional cueing in patients with brain lesions.
    Poggel DA; Kasten E; Müller-Oehring EM; Bunzenthal U; Sabel BA
    Brain Res; 2006 Jun; 1097(1):142-8. PubMed ID: 16777076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A functional interpretation of the visual fields of low vision patients.
    Jose R; Ferraro J
    J Am Optom Assoc; 1983 Oct; 54(10):885-93. PubMed ID: 6630838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does 'normal' vision improve with spinal manipulation?
    Stephens D; Gorman RF
    J Manipulative Physiol Ther; 1996; 19(6):415-8. PubMed ID: 8864973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The utilization of a temporal mirror coating on the back surface of the lens as a field enhancement device.
    Waiss B; Cohen JM
    J Am Optom Assoc; 1992 Aug; 63(8):576-80. PubMed ID: 1512409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Is it possible to compensate for visual field defects?].
    Lachenmayr B
    Ophthalmologe; 2006 May; 103(5):382-6. PubMed ID: 16283190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inapparent visual field defects in multiple sclerosis patients.
    Vidović T; Cerovski B; Vidović DH; Cerovski J; Novak-Laus K
    Coll Antropol; 2005; 29 Suppl 1():67-73. PubMed ID: 16193681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual field defect after pars plana vitrectomy.
    Yan H; Dhurjon L; Chow DR; Williams D; Chen JC
    Ophthalmology; 1998 Sep; 105(9):1612-6. PubMed ID: 9754165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vigabatrin associated visual field loss: a clinical audit to study prevalence, drug history and effects of drug withdrawal.
    Newman WD; Tocher K; Acheson JF
    Eye (Lond); 2002 Sep; 16(5):567-71. PubMed ID: 12194070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humphrey visual field analysis, visual field defects, and ophthalmic findings in patients with macro pituitary adenoma.
    Gedik S; Gur S; Atalay B; Colak M; Altinors N; Akova YA
    Saudi Med J; 2007 Sep; 28(9):1380-4. PubMed ID: 17768464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of visual field defects in leber hereditary optic neuropathy: experience of the LHON treatment trial.
    Newman NJ; Biousse V; Newman SA; Bhatti MT; Hamilton SR; Farris BK; Lesser RL; Turbin RE
    Am J Ophthalmol; 2006 Jun; 141(6):1061-1067. PubMed ID: 16765674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A child with epilepsy in whom multifocal VEPs facilitated the objective measurement of the visual field.
    Yukawa E; Kim YJ; Kawasaki K; Taketani F; Hara Y
    Epilepsia; 2005 Apr; 46(4):577-9. PubMed ID: 15816954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glaucomatous visual field defects: their characteristics and how to detect them.
    Kitazawa Y; Yamamoto T
    Clin Neurosci; 1997; 4(5):279-83. PubMed ID: 9292256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency-doubling perimetry: comparison with standard automated perimetry to detect glaucoma.
    Leeprechanon N; Giangiacomo A; Fontana H; Hoffman D; Caprioli J
    Am J Ophthalmol; 2007 Feb; 143(2):263-271. PubMed ID: 17178091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss.
    Medeiros FA; Sample PA; Weinreb RN
    Am J Ophthalmol; 2004 May; 137(5):863-71. PubMed ID: 15126151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.